OOIR: Observatory of International Research

Papers

(The H4-Index of Chinese Medical Journal is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Corrigendum: Obesity paradox in pulmonary hypertension secondary to chronic lung diseases	2348
Prescribing rate, healthcare utilization, and expenditure of older adults using potentially inappropriate medications in China: A nationwide cross-sectional study	108
Hepatocyte growth factor protects pulmonary endothelial barrier against oxidative stress and mitochondria-dependent apoptosis	87
An advanced machine learning method for simultaneous breast cancer risk prediction and risk ranking in Chinese population: A prospective cohort and modeling study	58
Systemic autoimmune diseases and recurrent pregnancy loss: research progress in diagnosis and treatment	56
Cancer epidemiological database linkage study of China: Design, methods, and quality evaluation	50
Transarterial chemoembolization refractoriness in hepatocellular carcinoma: Chinese College of Interventionalists definition and consensus statement	46
STAR Recommendations: A novel framework for generating recommendations	44
Comparing the effects of dual-task training and single-task training on walking, balance and cognitive functions in individuals with Parkinson’s disease: A systematic review	43
Proteome and genome integration analysis of obesity	43
Heart transplantation performance in China: Five-year experience after transplantation system reform	42
Efficacy and safety of perioperative intravenous lidocaine infusion for chronic postoperative pain	40
Radiotherapy and oncofertility: From physiological foundations to radiological perspectives	38
Health economic analysis and medical cost analysis of children with severe hepatitis B in China: A retrospective study from 2016 to 2022	38
Utility of the China-PAR Score in predicting secondary events among patients undergoing percutaneous coronary intervention	38
Obesity pandemic in China: epidemiology, burden, challenges, and opportunities	37
Autophagy in intestinal injury caused by severe acute pancreatitis	36
Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study	35
What is the "optimal formula" for donor selection and feces processing for fecal microbiota transplantation in ulcerative colitis?	33
Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment	32
Identifying coronary artery bypass grafting patients at high risk for adverse long-term prognosis using serial health-related quality of life assessments	32
Novel compound heterozygous variants in lectin mannose-binding 2-like gene identified in a Chinese autosomal recessive mental retardation-52 (MRT52) patient with phenotype expansion	32
Neoantigens in precision cancer immunotherapy: from identification to clinical applications	32
Identification of novel biomarkers for varicocele using iTRAQ LC-MS/MS technology	32
A multicenter study of the clinicopathological characteristics and a risk prediction model of early-stage breast cancer with hormone receptor-positive/human epidermal growth factor receptor 2-low expr	31

Association of psychological stress with wives’ hypertension across over 10 million Chinese married female population aged 20–49 years	31
SARS-CoV-2 infection and pregnancy: clinical update and perspective	29
Peri-procedural myocardial injury predicts poor short-term prognosis after TAVR: A single-center retrospective analysis from China	28
Atrial fibrillation: mechanism and clinical management	28